APA (7th ed.) Citation

J. O'Beirne, J.D. Mitchell, A. Sloss, B. Kay, S. Higgins, C. Orme, & A. Azzam. (2017). P43 FIB-4 is superior to APRI and identifies HCV patients with less significant fibrosis who could be managed in primary care. Elsevier.

Chicago Style (17th ed.) Citation

J. O'Beirne, J.D. Mitchell, A. Sloss, B. Kay, S. Higgins, C. Orme, and A. Azzam. P43 FIB-4 Is Superior to APRI and Identifies HCV Patients with Less Significant Fibrosis Who Could Be Managed in Primary Care. Elsevier, 2017.

MLA (9th ed.) Citation

J. O'Beirne, et al. P43 FIB-4 Is Superior to APRI and Identifies HCV Patients with Less Significant Fibrosis Who Could Be Managed in Primary Care. Elsevier, 2017.